Cell cycle-promoted factor CCNB1 can be targeted by VPS33B via c-Myc/p53/miR-192-3p to modulate the pathogenesis of non-small cell lung cancer (NSCLC) (51). Here, VPS33B is linked to non-small cell lung carcinoma.